https://www.maximizemarketresearch.com/market-report/orphan-drugs-market/342/ An orphan drug is used for the treatment of rare disorders. The patients suffering from rare disorders are less, and hence pharmaceutical industries do not interest in the manufacturing of drugs for the same. To deliver proper treatment for rare diseases and to motivate pharmaceutical and biotechnology companies to participate in treatment for rare diseases, governments have shaped several legal and financial incentives. The factors such as the rising occurrence of rare diseases and growing investment in R&D are expected to drive the growth of the orphan drug market. Also, the rising cases of neurological disorders will positively impact the healthy growth of the orphan drug market. The growing healthcare expenditure in developed and developing countries is expected to fuel the growth of the orphan drug market during the forecast period. Moreover, the increasing development of new technologies for orphan drugs is expected to generate a significant opportunity in the future. Stringent regulations in approving new developments in concern towards people's safety remains a significant challenging factor for the market players. Also, the lack of complete knowledge of the manufacturing process with the latest formula is obstructing the growth rate of the market. Continuous changes in government bodies' economic strategies in several countries may also adversely impact the demand for the global orphan drugs market.